FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912293422> ?p ?o ?g. }

• W2912293422 endingPage "598" @default.
• W2912293422 startingPage "587" @default.
• W2912293422 abstract "Anti-CD20 monoclonal antibodies (mAbs) rituximab and ofatumumab are potent activators of the classical complement pathway, and have been approved for the treatment of B-cell malignancies. However, complement exhaustion and overexpression of complement inhibitors by cancer cells diminish their therapeutic potential. The strategies of targeting membrane complement inhibitors by function-blocking antibodies and the supplementation with fresh frozen plasma have been proposed to overcome tumour cell resistance. We present a novel approach, which utilizes gain-of-function variants of complement factor B (FB), a component of alternative C3/C5 convertases, which augment mAb-activated reactions through a positive feedback mechanism called an amplification loop. If complement concentration is limited, an addition of quadruple gain-of-function FB mutant p.D279G p.F286L p.K323E p.Y363A (or selected single mutants) results in significantly increased complement-mediated lysis of ofatumumab-resistant tumour cells, as well as the complete lysis of moderately sensitive cells. Importantly, this effect cannot be achieved by further increasing ofatumumab concentration. Potentiation of cytotoxic effect towards moderately sensitive cells was less apparent at physiological serum concentration. However, an addition of hyperactive FB could compensate the loss of cytotoxic potential of serum collected from the NHL and CLL patients after infusion of rituximab. Residual levels of rituximab in such sera, in combination with added FB, were able to efficiently lyse tumour cells. We suggest that the administration of gain-of-function variants of FB can restore cytotoxic potential of complement-exhausted serum and maximize the therapeutic effect of circulating anti-CD20 mAbs." @default.
• W2912293422 created "2019-02-21" @default.
• W2912293422 creator A5007585070 @default.
• W2912293422 creator A5033866359 @default.
• W2912293422 creator A5041847501 @default.
• W2912293422 creator A5042252497 @default.
• W2912293422 creator A5046045272 @default.
• W2912293422 creator A5048175215 @default.
• W2912293422 creator A5074486986 @default.
• W2912293422 creator A5088252343 @default.
• W2912293422 date "2019-02-06" @default.
• W2912293422 modified "2023-10-17" @default.
• W2912293422 title "Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics" @default.
• W2912293422 cites W1643400449 @default.
• W2912293422 cites W1897592311 @default.
• W2912293422 cites W1963519109 @default.
• W2912293422 cites W1968451317 @default.
• W2912293422 cites W1978185343 @default.
• W2912293422 cites W1990682997 @default.
• W2912293422 cites W2000365588 @default.
• W2912293422 cites W2009994712 @default.
• W2912293422 cites W2012521762 @default.
• W2912293422 cites W2015948025 @default.
• W2912293422 cites W2026784781 @default.
• W2912293422 cites W2039226259 @default.
• W2912293422 cites W2046614465 @default.
• W2912293422 cites W2049372901 @default.
• W2912293422 cites W2054774042 @default.
• W2912293422 cites W2059277241 @default.
• W2912293422 cites W2072011311 @default.
• W2912293422 cites W2074889157 @default.
• W2912293422 cites W2077144266 @default.
• W2912293422 cites W2079089580 @default.
• W2912293422 cites W2096298901 @default.
• W2912293422 cites W2096987199 @default.
• W2912293422 cites W2109775395 @default.
• W2912293422 cites W2124841845 @default.
• W2912293422 cites W2127676844 @default.
• W2912293422 cites W2132467087 @default.
• W2912293422 cites W2141139539 @default.
• W2912293422 cites W2147639736 @default.
• W2912293422 cites W2159895229 @default.
• W2912293422 cites W2294306447 @default.
• W2912293422 cites W2726273490 @default.
• W2912293422 cites W2782977481 @default.
• W2912293422 cites W2789265197 @default.
• W2912293422 cites W33733012 @default.
• W2912293422 cites W4231652458 @default.
• W2912293422 doi "https://doi.org/10.1007/s00262-019-02304-0" @default.
• W2912293422 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6447516" @default.
• W2912293422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30725204" @default.
• W2912293422 hasPublicationYear "2019" @default.
• W2912293422 type Work @default.
• W2912293422 sameAs 2912293422 @default.
• W2912293422 citedByCount "6" @default.
• W2912293422 countsByYear W29122934222020 @default.
• W2912293422 countsByYear W29122934222021 @default.
• W2912293422 countsByYear W29122934222023 @default.
• W2912293422 crossrefType "journal-article" @default.
• W2912293422 hasAuthorship W2912293422A5007585070 @default.
• W2912293422 hasAuthorship W2912293422A5033866359 @default.
• W2912293422 hasAuthorship W2912293422A5041847501 @default.
• W2912293422 hasAuthorship W2912293422A5042252497 @default.
• W2912293422 hasAuthorship W2912293422A5046045272 @default.
• W2912293422 hasAuthorship W2912293422A5048175215 @default.
• W2912293422 hasAuthorship W2912293422A5074486986 @default.
• W2912293422 hasAuthorship W2912293422A5088252343 @default.
• W2912293422 hasBestOaLocation W29122934221 @default.
• W2912293422 hasConcept C111684460 @default.
• W2912293422 hasConcept C154317977 @default.
• W2912293422 hasConcept C159654299 @default.
• W2912293422 hasConcept C171279029 @default.
• W2912293422 hasConcept C18031839 @default.
• W2912293422 hasConcept C185592680 @default.
• W2912293422 hasConcept C189446657 @default.
• W2912293422 hasConcept C202751555 @default.
• W2912293422 hasConcept C203014093 @default.
• W2912293422 hasConcept C2777726029 @default.
• W2912293422 hasConcept C2778714382 @default.
• W2912293422 hasConcept C2780653079 @default.
• W2912293422 hasConcept C40677261 @default.
• W2912293422 hasConcept C502942594 @default.
• W2912293422 hasConcept C542903549 @default.
• W2912293422 hasConcept C55493867 @default.
• W2912293422 hasConcept C71924100 @default.
• W2912293422 hasConceptScore W2912293422C111684460 @default.
• W2912293422 hasConceptScore W2912293422C154317977 @default.
• W2912293422 hasConceptScore W2912293422C159654299 @default.
• W2912293422 hasConceptScore W2912293422C171279029 @default.
• W2912293422 hasConceptScore W2912293422C18031839 @default.
• W2912293422 hasConceptScore W2912293422C185592680 @default.
• W2912293422 hasConceptScore W2912293422C189446657 @default.
• W2912293422 hasConceptScore W2912293422C202751555 @default.
• W2912293422 hasConceptScore W2912293422C203014093 @default.
• W2912293422 hasConceptScore W2912293422C2777726029 @default.
• W2912293422 hasConceptScore W2912293422C2778714382 @default.
• W2912293422 hasConceptScore W2912293422C2780653079 @default.
• W2912293422 hasConceptScore W2912293422C40677261 @default.

• next